Advanced

Predictors of Successful Cardioversion with Vernakalant in Patients with Recent-Onset Atrial Fibrillation.

Mochalina, Natalia LU ; Juhlin, Tord LU ; Öhlin, Bertil LU ; Carlson, Jonas LU ; Holmqvist, Fredrik LU and Platonov, Pyotr LU (2015) In Annals of Noninvasive Electrocardiology 20(2). p.140-147
Abstract
Vernakalant is a novel atrial-selective antiarrhythmic drug able to convert recent-onset atrial fibrillation (AF) with reportedly low proarrhythmic risk. Successful cardioversion predictors are largely unknown. We sought to evaluate clinical and electrocardiographic predictors of cardioversion of recent-onset AF with vernakalant.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Annals of Noninvasive Electrocardiology
volume
20
issue
2
pages
140 - 147
publisher
Wiley-Blackwell
external identifiers
  • pmid:25040826
  • wos:000352015500006
  • scopus:84925956328
ISSN
1082-720X
DOI
10.1111/anec.12178
language
English
LU publication?
yes
id
8ac7d700-74c6-4a75-b879-f4926112e70d (old id 4581826)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25040826?dopt=Abstract
date added to LUP
2014-08-08 18:06:14
date last changed
2017-11-19 03:11:34
@article{8ac7d700-74c6-4a75-b879-f4926112e70d,
  abstract     = {Vernakalant is a novel atrial-selective antiarrhythmic drug able to convert recent-onset atrial fibrillation (AF) with reportedly low proarrhythmic risk. Successful cardioversion predictors are largely unknown. We sought to evaluate clinical and electrocardiographic predictors of cardioversion of recent-onset AF with vernakalant.},
  author       = {Mochalina, Natalia and Juhlin, Tord and Öhlin, Bertil and Carlson, Jonas and Holmqvist, Fredrik and Platonov, Pyotr},
  issn         = {1082-720X},
  language     = {eng},
  number       = {2},
  pages        = {140--147},
  publisher    = {Wiley-Blackwell},
  series       = {Annals of Noninvasive Electrocardiology},
  title        = {Predictors of Successful Cardioversion with Vernakalant in Patients with Recent-Onset Atrial Fibrillation.},
  url          = {http://dx.doi.org/10.1111/anec.12178},
  volume       = {20},
  year         = {2015},
}